ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
2,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
4,1,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
5,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
6,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
7,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
9,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
9,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
11,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
12,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
14,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
15,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
16,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
17,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
18,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
19,1,Neurofibromatosis,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
20,1,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
21,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
22,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,Y
23,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
24,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
24,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
25,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
26,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
27,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
28,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
